April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Paolo Tarantino: The OXEL trial is out on Nature Communications
Apr 2, 2024, 05:37

Paolo Tarantino: The OXEL trial is out on Nature Communications

Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on X/Twitter:

The OXEL trial, led by Filipa Lynce, is out on Nature Communications. Among 45 pts with residual TNBC after NAT, adjuvant Nivolumab/Capecitabine were well tolerated, increased peripheral immune score and led to numerically improved 2 year iDFS (91%) vs nivo (47%) or cape alone (53%). “

Source: Paolo Tarantino/X